¼¼°èÀÇ ÇǺΠ¹è¸®¾î ½ÃÀå
Skin Barriers
»óǰÄÚµå : 1793827
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 382 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,209,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,629,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇǺΠ¹è¸®¾î ¼¼°è ½ÃÀåÀº 2030³â±îÁö 4¾ï 1,040¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 3¾ï 5,990¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇǺΠ¹è¸®¾î ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 4¾ï 1,040¸¸ ´Þ·¯¿¡ ´ÞÇϰí, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 2.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÇǺΠ¹è¸®¾î ½ºÇÁ·¹ÀÌ´Â CAGR 1.7%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2¾ï 380¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸ðÀ̽ºÃ³ ¹è¸®¾î Å©¸² ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 9,800¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, Áß±¹Àº CAGR 4.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ´Â

¹Ì±¹ÀÇ ÇǺΠ¹è¸®¾î ½ÃÀåÀº 2024³â¿¡ 9,800¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 7,740¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 4.2%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 0.8%¿Í 1.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÇǺΠ¹è¸®¾î ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÇǺΠ¹è¸®¾î°¡ »óó, Àå·ç, ¿ä½Ç±Ý °ü¸®¿¡ ÇʼöÀûÀÎ Á¸Àç°¡ µÇ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

ÇǺΠ¹è¸®¾î´Â ¼öºÐ, Á¢ÂøÁ¦, ¸¶Âû, È­ÇÐÀû ÀÚ±ØÀ¸·ÎºÎÅÍ ÇǺθ¦ º¸È£Çϵµ·Ï ¼³°èµÈ º¸È£ Á¦Ç°À¸·Î Àå·ç, ¸¸¼º »óó, ¿ä½Ç±Ý °ü·Ã ÇǺο°(IAD) °ü¸®¿¡ ÀÖ¾î Áß¿äÇÑ ¿ä¼Ò·Î ÀÛ¿ëÇÕ´Ï´Ù. ÇǺΠ¹è¸®¾î´Â Ç×¹® ÁÖÀ§³ª »óó ÁÖº¯¿¡ ¹ÝÅõ°ú¼º Åë±â¼º ÃþÀ» Çü¼ºÇÏ¿© ÇǺΠÆÄ±«¸¦ ¹æÁöÇϰí Ä¡À¯¸¦ ÃËÁøÇϸç, Àå·ç ÁָӴϳª »óó µå·¹½Ì°ú °°Àº ÀÇ·á±â±âÀÇ ¹ÐÂø¼ºÀ» ³ôÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¦Á¦´Â ¹°Æ¼½´, ½ºÇÁ·¹ÀÌ, Å©¸², ¸µ, ÆäÀ̽ºÆ® µîÀ¸·Î Á¦°øµÇ¸ç, ÀÇ·á¿ë Á¡ÂøÁ¦ °ü·Ã ÇǺΠ¼Õ»ó(MARSI)À» ÁÙÀ̰í ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½ÃŰ´Â ´É·ÂÀ¸·Î ÀÎÇØ ÇöÀç ±Þ¼º±â ÀÇ·á ¹× ÀçÅà ȯ°æ ¸ðµÎ¿¡¼­ Ç¥ÁØÀÌ µÇ°í ÀÖ½À´Ï´Ù.

´ëÀå¾Ï, Å©·Ðº´, ´ç´¢º´, ¿åâ°ú °°Àº ¸¸¼ºÁúȯ¿¡ ´ëÇÑ Àü¼¼°èÀûÀÎ ºÎ´ã Áõ°¡´Â ÷´Ü ÇǺÎÀ庮 Á¦Ç°ÀÇ ¼ö¿ä¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¼ö¼ú ÈÄ Àå·ç ȯÀÚ, ¿ä½Ç±Ý ³ëÀÎ, ºÒ±¸¿Í °ü·ÃµÈ ÇǺΠ¼Õ»óÀ» ÀÔÀº ȯÀÚµéÀº ÀÏ»ó »ýȰÀÇ ÁúÀ» ³ôÀ̱â À§ÇØ Á¡Á¡ ´õ ÀÌ·¯ÇÑ À庮 Á¦Ç°¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ç¥ÁØÈ­µÈ Àå·ç °ü¸® ÇÁ·ÎÅäÄݰú »óó °ü¸® ¹øµé¿¡ ÇǺΠ¹è¸®¾î Á¦Ç°À» ÅëÇÕÇÔÀ¸·Î½á, ƯÈ÷ ¿ä¾ç¿ø, ÁßȯÀÚ½Ç, Àå±â ¿ä¾ç ȯ°æ¿¡¼­ ºñ¿ëÀÌ ¸¹ÀÌ µå´Â ÇǺΠÇÕº´ÁõÀ» ¿¹¹æÇÏ°í °£º´ÀÎÀÇ ºÎ´ãÀ» ÁÙÀÌ´Â µ¥ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

Á¦Ç°ÀÇ Çõ½Å¼º, Á¦Çü, ÀûÇÕ¼º¿¡ µû¶ó ½Ç¿ë¼º°ú äÅ÷üÀÌ ¾î¶»°Ô Çâ»óµÇ°í Àִ°¡?

ÇǺΠ¹è¸®¾îÀÇ Ã³¹æÀº ³»±¸¼º, ÀúÀڱؼº, ´Ù¸¥ ÀÇ·á Á¦Ç°°úÀÇ È£È¯¼ºÀ» Çâ»ó½Ã۱â À§ÇØ Å« ÁøÀüÀ» ÀÌ·ç¾ú½À´Ï´Ù. ±âÁ¸ÀÇ ÆäÆ®·Ñ¶óŽ ±â¹Ý Á¦Á¦´Â Æó¼âÀûÀ̸鼭µµ Åë±â¼º ÀÖ´Â º¸È£¸·À» Çü¼ºÇÏ´Â °íºÐÀÚ ÇǺΠ¹è¸®¾î Çʸ§À̳ª Æåƾ ±â¹Ý ÇÏÀ̵å·ÎÄÝ·ÎÀ̵å(Pectin-based hydrocolloid)·Î ´ëüµÇ°í ÀÖ½À´Ï´Ù. ÀÌ Â÷¼¼´ë À庮Àº ³ôÀº ¼öºÐ ³ëÃâ°ú ±â°èÀû ½ºÆ®·¹½º¿¡µµ ÇǺÎÀÇ ¹«°á¼ºÀ» À¯ÁöÇϸ鼭µµ ÀÚÁÖ ¹Ù¸£±â¿¡ ÃæºÐÇÑ ºÎµå·¯¿òÀ» À¯ÁöÇÕ´Ï´Ù. Ç×±ÕÁ¦ ÷°¡Á¦´Â Ç×¹® ÁÖÀ§ ¹× »óó ÁÖº¯ ȯ°æÀÇ °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇØ ÀϺΠÁ¦Á¦¿¡ ÷°¡µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¶ÇÇÑ Á¦Ç° Àü´Þ ÇüŰ¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Çʸ§°ú ½ºÇÁ·¹ÀÌ´Â ³ëÅÍÄ¡ ¹æ½ÄÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ¾î ¼ö¼úÀ̳ª ¸¸¼º±â ÀÇ·á¿¡¼­ 2Â÷ ¿À¿°À» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹è¸®¾î¸µ°ú ÆäÀ̽ºÆ®´Â ÇǺÎÀÇ ÁÖ¸§°ú ºÒ±ÔÄ¢ÇÑ À±°ûÀ» ä¿ì´Â µ¥ »ç¿ëµÇ¸ç, Àå·ç±â±¸ÀÇ Á¢ÂøÀ» À§ÇØ ±ÕÀÏÇÑ Ç¥¸éÀ» ¸¸µì´Ï´Ù. °í±Þ Á¦Ç° Áß¿¡´Â »ïÃâ¾×ÀÌ ¸¹Àº ȯÀÚ³ª ½ÀÀ±¼º ÇǺÎÁúȯ(MASD) ȯÀÚ¸¦ À§ÇØ Èí¼ö ÃËÁøÁ¦¸¦ ÇÔÀ¯ÇÑ Á¦Ç°µµ ÀÖ°í, ¹Ú¸® ½Ã Á¡Âø¼º ¿Ü»óÀ» ÃÖ¼ÒÈ­Çϵµ·Ï ¼³°èµÈ Á¦Ç°µµ ÀÖ½À´Ï´Ù. ½Ç¸®ÄÜ µå·¹½ÌÀç, À½¾Ðâ»óÄ¡·á(NPWT), ÇÏÀ̵å·ÎÆÄÀ̹ö µå·¹½ÌÀç¿ÍÀÇ È£È¯¼ºÀº ƯÈ÷ ´ÙÃþ »óó Ä¡·á ¿ä¹ý¿¡¼­ Á¦Ç°ÀÇ Å« Â÷º°È­ ¿ä¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÇǺΠ¹è¸®¾î Á¦Ç°Àº ÇöÀç ¼Ò¾Æ Àå·ç º¸È£ºÎÅÍ ÁßÁõ »óó °ü¸®, Àå±â ¿ä½Ç±Ý °ü¸®±îÁö »ç¿ë »ç·Ê¿¡ µû¶ó Á¶Á¤µÇ°í ÀÖ½À´Ï´Ù. ¼Ò¾Æ¿ë Á¦Ç°Àº ¸Å¿ì ºÎµå·¯¿î Æ÷¹Ä·¯·Î ¼³°èµÇ¾úÀ¸¸ç, ºñ¸¸ ȯÀÚ¸¦ À§ÇÑ Á¦Ç°Àº ´õ ³ÐÀº Ç¥¸éÀûÀ» Ä¿¹öÇϰí Èí¼ö·ÂÀ» ³ô¿´½À´Ï´Ù. ¹«Çâ, ¹«¾ËÄÚ¿Ã, ¹«»ö¼Ò À庮 µî ȯÀÚ Áß½ÉÀÇ Çõ½ÅÀº ¹Î°¨ÇÑ ÇǺÎÀÇ ÇǺΰúÇÐÀû ±âÁØÀ» ÃæÁ·ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº ÀÓ»ó ¹× ȨÄÉ¾î ºÐ¾ß¿¡¼­ Æø³ÐÀº äÅÃÀ» ÃËÁøÇϰí ȯÀÚÀÇ ¼øÀÀµµ¿Í Àå±âÀûÀÎ ÇǺΠ°á°ú¸¦ °³¼±ÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå È®´ë¸¦ ÁÖµµÇÏ´Â ÇコÄɾî ȯ°æ°ú À¯Åë ä³ÎÀº?

º´¿ø°ú ¼ö¼ú ¼¾ÅÍ´Â ±Þ¼º Àå·ç ¼³Ä¡, ¼ö¼ú ÈÄ »óó °ü¸®, Ä«Å×ÅÍ °ü¸® µîÀÇ ¿ªÇÒ·Î ÀÎÇØ ÇǺΠ¹è¸®¾î »ç¿ëÀÇ Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Àå±â¿ä¾ç½Ã¼³, ¿ä¾ç¿ø, Àç°¡ ÀÇ·á ¼­ºñ½º¿¡¼­´Â ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸ÀÇ ¿ä½Ç±Ý ¹× ¸¸¼º »óóÀÇ À¯º´·ü Áõ°¡¿Í ÇÔ²² ³ëÀÎ °£È£ ¸ðµ¨·ÎÀÇ ÀüȯÀº ÀçÅà ȯ°æ¿¡¼­ÀÇ ÇǺΠ¹è¸®¾î ¼Òºñ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °£º´ÀÎ ±³À°, ¿ø°ÝÀÇ·á Áö¿ø, Á¤±â ±¸¸Å ±â¹Ý ¹è¼Û ¸ðµ¨Àº ÀçÅà ȯÀÚÀÇ ÀϰüµÈ Á¦Ç° »ç¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¼Ò¸Å ¹× E-Commerce À¯Åë ä³ÎÀº ƯÈ÷ ºÏ¹Ì¿Í ¼­À¯·´¿¡¼­ Å©°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. Àå·ç ¹× »óó °ü¸® ºê·£µå´Â D2C ¸ðµ¨À» Ȱ¿ëÇÏ¿© ¸ÂÃãÇü Á¦Ç° ŰƮ, ´«¿¡ Àß ¶çÁö ¾Ê´Â Æ÷Àå, ÀÚµ¿ ÀçÁÖ¹® ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ¾à±¹À̳ª ÀÇ·á¿ëǰÁ¡Àº ƯÈ÷ µðÁöÅÐ º¸±Þ·üÀÌ ³·Àº ½ÅÈï ½ÃÀå¿¡¼­ ¿öÅ©ÀÎ ±¸¸Å¿¡ ÀÖ¾î ÇʼöÀûÀÎ Á¸Àç·Î ³²¾Æ ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦±¹¿¡¼­´Â ÇǺΠ¹è¸®¾î Á¦Ç°¿¡ ´ëÇÑ °ø°ø ¹× ¹Î°£ º¸Çè Àû¿ëÀÌ °³¼±µÇ°í ÀÖÀ¸¸ç, Àü ¼¼°è º¸°Ç ±â°ü°ú NGO´Â ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æÀ» À§ÇÑ ¸¸¼º »óó °ü¸® ŰƮ¿¡ ÀÌ·¯ÇÑ Á¦Ç°À» Æ÷ÇÔ½Ã۰í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, °£È£»ç, »óó °ü¸® Àü¹®°¡, Àå·ç Ä¡·á»ç¸¦ À§ÇÑ ±³À° ¹× ÈÆ·Ã ÇÁ·Î±×·¥À» ÅëÇØ Á¦Ç°ÀÇ ¿Ã¹Ù¸¥ »ç¿ë¹ý°ú ȯÀÚÀÇ ÁؼöÀ²À» ³ôÀ̰í ÀÖ½À´Ï´Ù. EMR°ú Äɾî Ç÷¡´× Ç÷§Æû¿¡¼­ ½ºÅ²ÄÉ¾î ¾Ë°í¸®ÁòÀÇ º¸±ÞÀº ±Ù°Å¿¡ ±â¹ÝÇÑ À庮 Á¦Ç° ¼±ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÅëÇÕ Ä¡·á °æ·ÎÀÇ Ç¥ÁØÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó ÀÇ·á ½Ã½ºÅÛ ³» ó¹æ ¹èÄ¡¿Í ºê·£µå ¼±È£µµ°¡ Á¦Ç° äÅðú ½ÃÀå Á¡À¯À²À» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

ÇǺΠ¹è¸®¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ Àü ¼¼°è ¼ö¿ä¸¦ µÞ¹ÞħÇÏ´Â ÃËÁø¿äÀÎÀº ¹«¾ùÀϱî?

¼¼°è ÇǺΠ¹è¸®¾î ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼ºÁúȯÀÇ È®»ê, ¼ö¼ú ÈÄ °ü¸® ¼ö¿ä, ¼¼°è Àα¸ÀÇ °í·ÉÈ­ µî ¿©·¯ °¡Áö »óÈ£ ¿¬°üµÈ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¾Ï°ú ¿°Áõ¼º ÀåÁúȯÀÇ À¯ÇàÀ¸·Î Àå·ç ¼ö¼ú °Ç¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ Àå·ç ÁÖº¯ ÇǺΠ°ü¸®ÀÇ Çʿ伺µµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î, ¿åâ, ´ç´¢¼º ±Ë¾ç, IADÀÇ Áõ°¡·Î ÀÎÇØ ħ»ó ȯÀÚ¿¡¼­ ¿åâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó »óó Ä¡·áÀÇ ¿ëµµ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ½Ã¼³ ¹× Àç°¡ ȯ°æ¿¡¼­ÀÇ ³ëÀÎ ¿ä½Ç±Ý ¿ëǰ »ç¿ëÀº MASD¸¦ ¿¹¹æÇÏ´Â ¹è¸®¾î Å©¸²°ú ¹°Æ¼½´ÀÇ ¼ö¿ä ±ÞÁõ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Çõ½Åµµ ¼ºÀåÀÇ ±âÆøÁ¦ÀÔ´Ï´Ù. À庮ÀÇ ³»±¸¼º, Á¦Á¦ÀÇ ¾ÈÀü¼º, Àû¿ëÀÇ ¿ëÀ̼º, Á¢ÂøÁ¦ ¹× µå·¹½Ì Àç·á¿ÍÀÇ ÀûÇÕ¼ºÀÇ ¹ßÀüÀº ÀÓ»ó °á°ú¿Í ȯÀÚ ¸¸Á·µµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °£È£ Ä¿¸®Å§·³°ú ÀÓ»ó °¡À̵å¶óÀο¡¼­ MARSI¿Í ÇǺΠ¹«°á¼º ¸ð¹ü »ç·Ê¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ´Ù¾çÇÑ Ä¡·á ÇöÀå¿¡¼­ À庮 Á¦Ç°ÀÇ ÀÏ»óÀûÀÎ »ç¿ëÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ÄÉ¾î ¹øµé, QIPP ÀÌ´Ï¼ÅÆ¼ºê, º´¿ø³» °¨¿° °¨¼Ò ÇÁ·Î±×·¥¿¡ ÇǺΠ¹è¸®¾îÀÇ »ç¿ëÀÌ ¿¹¹æ Ç¥ÁØÀ¸·Î Á¦µµÈ­µÇ¾î ÀÖ½À´Ï´Ù.

»óó ¹× Àå·ç Ä¡·á ±âÁØÀÇ ¼¼°èÈ­, º¸Çè Àû¿ë È®´ë, ÀÇ·áºñ Áõ°¡·Î ÀÎÇØ ½ÅÈï±¹ÀÇ ½ÃÀå ¼ºÀåÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. À庮 Á¦Ç° Á¦Á¶¾÷ü¿Í »óó °ü¸® ±â±â Á¦Á¶¾÷üÀÇ Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ °øµ¿ ÆÐŰÁö ¼Ö·ç¼Ç ¹× ÅëÇÕ Äɾî Á¦°øÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ȨÄɾ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Â ÀÇ·á Á¦°ø ȯ°æÀ̰í, ¸¸¼º ÇǺÎÁúȯÀÇ Áõ°¡°¡ ¿¹»óµÊ¿¡ µû¶ó ÇǺÎÀ庮Àº ÇâÈÄ ¸î ³â µ¿¾È ¿©·¯ ºÎ¹®¿¡¼­ Áö¼ÓÀûÀÎ È®ÀåÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(ÇǺΠ¹è¸®¾î ½ºÇÁ·¹ÀÌ, ¼öºÐ ¹è¸®¾î Å©¸², º¸È£ ¿¬°í, ±âŸ Á¦Ç°), ÀûÀÀÁõ(¿ä½Ç±Ý¡¤¿À½ºÅä¹Ì, ¸¸¼º »óó, ¿åâ, ÇǺο°¡¤°Ç¼º ÇǺÎ, ¾ÆÅäÇÇ ÇǺο°), À¯Åë ä³Î(½Ã¼³ ÆÇ¸Å, ¼Ò¸Å ÆÇ¸Å)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Skin Barriers Market to Reach US$410.4 Million by 2030

The global market for Skin Barriers estimated at US$359.9 Million in the year 2024, is expected to reach US$410.4 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Skin Barrier Sprays, one of the segments analyzed in the report, is expected to record a 1.7% CAGR and reach US$203.8 Million by the end of the analysis period. Growth in the Moisture Barrier Creams segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$98.0 Million While China is Forecast to Grow at 4.2% CAGR

The Skin Barriers market in the U.S. is estimated at US$98.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$77.4 Million by the year 2030 trailing a CAGR of 4.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 1.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Skin Barriers Market - Key Trends & Drivers Summarized

Why Are Skin Barriers Becoming Indispensable in Wound, Ostomy, and Incontinence Management?

Skin barriers-protective products designed to shield the skin from moisture, adhesives, friction, and chemical irritants-have become critical components in the management of ostomies, chronic wounds, and incontinence-associated dermatitis (IAD). By forming a semi-permeable, breathable layer over peristomal or periwound areas, skin barriers prevent skin breakdown, promote healing, and enhance the adherence of medical devices such as ostomy pouches or wound dressings. These formulations, available in wipes, sprays, creams, rings, and pastes, are now standard in both acute care and home settings due to their ability to reduce medical adhesive-related skin injury (MARSI) and improve patient comfort.

The rising global burden of chronic conditions such as colorectal cancer, Crohn-s disease, diabetes, and pressure ulcers is directly influencing demand for advanced skin barrier products. Post-surgical stoma patients, incontinent elderly individuals, and those with immobility-related skin injuries are increasingly reliant on these barriers for daily quality of life. Furthermore, the integration of skin barrier products into standardized ostomy care protocols and wound care bundles-especially in nursing homes, ICUs, and long-term care settings-has made them indispensable in preventing costly skin complications and reducing caregiver burden.

How Are Product Innovations, Formulations, and Compatibility Enhancing Utility and Adoption?

Significant strides have been made in the formulation of skin barriers to improve their durability, hypoallergenicity, and compatibility with other medical products. Traditional petrolatum-based formulas are being replaced with polymeric skin barrier films and pectin-based hydrocolloids that form occlusive yet breathable shields. These new-generation barriers maintain skin integrity under high moisture exposure and mechanical stress while remaining gentle enough for frequent application. Antimicrobial additives are being incorporated into select formulations to reduce infection risk in peristomal and periwound environments.

The market has also witnessed an expansion in product delivery formats. Films and sprays offer no-touch application, minimizing cross-contamination in surgical and chronic care settings. Barrier rings and pastes are used to fill skin creases or irregular contours, creating an even surface for ostomy appliance adhesion. Some advanced products include absorption-enhancing agents for patients with heavy exudate or moisture-associated skin damage (MASD), while others are designed to minimize adhesive trauma during removal. Compatibility with silicone dressings, negative pressure wound therapy (NPWT), and hydrofiber dressings is becoming a major product differentiator, particularly in multi-layered wound care regimens.

Moreover, skin barrier products are now tailored by use case-ranging from pediatric ostomy protection to critical care wound management and long-term incontinence care. Pediatric variants are designed with ultra-gentle formulations, while bariatric-specific lines offer larger surface area coverage and increased absorption. Patient-centric innovations such as scent-free, alcohol-free, and dye-free barriers are helping meet dermatological standards for sensitive skin. These developments are facilitating broader adoption across clinical and home care segments, enhancing patient adherence and long-term skin outcomes.

Which Healthcare Settings and Distribution Channels Are Driving Market Expansion?

Hospitals and surgical centers continue to account for a significant share of skin barrier usage due to their role in acute ostomy creation, post-operative wound care, and catheter management. However, demand is growing rapidly in long-term care facilities, nursing homes, and home health services. The shift toward aging-in-place care models, coupled with the increasing prevalence of incontinence and chronic wounds among geriatric populations, is driving skin barrier consumption in home settings. Caregiver education, telemedicine support, and subscription-based delivery models are facilitating consistent product usage among at-home patients.

Retail and e-commerce distribution channels are expanding significantly, particularly in North America and Western Europe. Ostomy and wound care brands are leveraging D2C models to provide customizable product kits, discreet packaging, and automatic reorder services. Pharmacies and medical supply stores remain critical for walk-in purchases, particularly in emerging markets where digital penetration is lower. Public and private insurance coverage for skin barrier products is improving in developed economies, while global health agencies and NGOs are including these products in chronic wound care kits for resource-limited settings.

Additionally, training and education programs for nurses, wound care specialists, and stoma therapists are reinforcing correct product usage and patient compliance. The proliferation of skin care algorithms in EMRs and care planning platforms is promoting evidence-based barrier product selection. As integrated care pathways become more standardized, formulary placement and brand preference within health systems are becoming key drivers of product adoption and market share.

What Growth Drivers Are Sustaining Global Demand for Skin Barrier Solutions?

The growth in the global skin barriers market is driven by several interrelated factors anchored in chronic disease prevalence, post-surgical care demands, and the aging global population. As the number of ostomy surgeries rises-fueled by cancer and inflammatory bowel disease prevalence-so too does the need for effective peristomal skin management. Similarly, increasing rates of pressure injuries, diabetic ulcers, and IAD among bedridden patients are expanding the wound care applications of skin barriers. Incontinence product usage among the elderly, particularly in institutional and at-home settings, is contributing to the surge in demand for barrier creams and wipes that prevent MASD.

Innovation is another growth catalyst. Advances in barrier durability, formulation safety, ease of application, and compatibility with adhesives and dressings are enhancing clinical outcomes and patient satisfaction. Furthermore, increased awareness of MARSI and skin integrity best practices in nursing curricula and clinical guidelines is driving routine use of barrier products in diverse care settings. Inclusion in care bundles, QIPP initiatives, and hospital-acquired condition reduction programs is institutionalizing skin barrier use as a preventive standard.

Globalization of wound and ostomy care standards, expanding access to insurance coverage, and rising health expenditure are fostering market growth across emerging economies. Strategic partnerships between barrier product manufacturers and wound care device firms are leading to co-packaged solutions and integrated care offerings. With home care becoming the fastest-growing delivery setting and chronic skin conditions projected to rise, skin barriers are positioned for sustained, multi-segment expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Skin Barriers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Skin Barrier Sprays, Moisture Barrier Creams, Protective Ointments, Other Products); Indication (Incontinence & Ostomy Indication, Chronic Wounds Indication, Pressure Ulcers Indication, Skin Rash & Dry Skin Indication, Atopic Dermatitis Indication); Distribution Channel (Institutional Sales Distribution Channel, Retail Sales Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â